中文名稱:馬來酸氟伏沙明 | 英文名稱:Fluvoxamine (DU-23000) maleate |
CAS:61718-82-9 | 品牌: 阿拉丁 |
產(chǎn)地: 上海 | 保存條件: -80℃儲存 |
純度規(guī)格: 10mM in DMSO | 產(chǎn)品類別: 藥靶配體 藥靶配體 |
分子式: C14H18F3N2O2·C4H4O4 | 分子量: 434.41 |
運輸條件: 超低溫冰袋運輸 | 產(chǎn)品規(guī)格: 1ml |
貨號: F409149 | 是否進(jìn)口: 否 |
中文名:馬來酸氟伏沙明
英文名:Fluvoxamine (DU-23000) maleate
英文別名:MK-264;1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate
純度:10mM in DMSO
貨號:F409149
包裝:1ml
Cas號:61718-82-9
存儲溫度:-80℃儲存
產(chǎn)品介紹:
Information
Fluvoxamine (DU-23000) maleate Fluvoxamine maleate (DU-23000, MK-264) is a selective serotonin (5-HT) reuptake inhibitor (SSRI), used in the treatment of obsessive-compulsive disorder.
In?vitro
Fluvoxamine increases [5-HT]ex levels in rat the prefrontal cortex and thalamus, and also increases [DA]ex levels in the striatum. Fluvoxamine maleate ameliorates tactile allodynia via spinal 5-HT2A/2C receptors, by acting on the receptors or 5-HT neurons.
In?vivo
Fluvoxamine maleate also exhibits the antinociception in a dose-dependent manner in the paw pressure test in non-ligated mice. Fluvoxamine maleate also induces antinociceptive effect in the acute paw pressure test, and this effect is antagonized by the 5-HT3 receptor antagonist granisetron. Fluvoxamine (10 and 30 mg/kg, i.p.) enhances synaptic efficacy in the hippocampo-mPFC pathway in a dose-dependent manner in the rat hippocampo-medial prefrontal cortex (mPFC). Fluvoxamine (10 and 30 mg/kg, i.p.) suppresses long-term potentiation (LTP) in the hippocampal CA1 field of anesthetized rats. Fluvoxamine (30 mg/kg, i.p.)-induced suppression of LTP is completely reversed by the 5-HT(1A) receptor antagonist NAN-190 (0.5 mg/kg, i.p), but not by the 5-HT(4) receptor antagonist GR 113808 (20 mg/rat, i.c.v.) and the 5-HT(7) receptor antagonist DR 4004 (10 mg/rat, i.c.v.). Fluvoxamine maleate reinforces the response to norepinephrine of isolated rat vas deferens incubated in Krebs-Henseleit solution. Fluvoxamine maleate and Fluoxetine hydrochloride inhibit the contraction induced by potassium ion on the isolated rat uterus preparation with IC50 of 3.99μM and 18.2μM, respectively.
Cell?Data
cell?lines:MC 11060 cells
Concentrations:
Incubation?Time:
Powder?Purity:≥99%
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對應(yīng)頁面:https://www.aladdin-e.com/zh_cn/F409149.html
成立日期 | 2009-03-16 (16年) | 注冊資本 | 14130.676萬人民幣 |
員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 生物化工,化學(xué)試劑 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP1年
|
普善實業(yè)(陜西)有限公司
|
2025-02-26 | |
詢價 |
VIP9年
|
武漢維斯?fàn)柭锕こ逃邢薰?/div>
|
2025-02-26 | |
詢價 |
VIP3年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2025-02-26 | |
詢價 |
VIP4年
|
江西瑞威爾生物科技有限公司
|
2025-02-25 | |
詢價 |
VIP4年
|
河北陌槿生物科技有限公司
|
2025-02-25 | |
詢價 |
VIP4年
|
湖北辰心藥業(yè)有限公司
|
2025-02-24 | |
¥7000 |
VIP3年
|
山東銳順?biāo)帢I(yè)有限公司
|
2025-02-19 | |
詢價 |
中國食品藥品檢定研究院
|
2025-02-18 | ||
詢價 |
VIP1年
|
廣州佳途科技股份有限公司
|
2025-02-05 | |
詢價 |
VIP3年
|
江西瑞威爾生物科技有限公司
|
2025-02-05 |